Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 9/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.75 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.75 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.75 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.75 |
| ▸ | HPGD | P15428 | 3/20 | 0.75 |
| ▸ | TSHR | P16473 | 2/20 | 0.75 |
| ▸ | MEN1 | O00255 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.75 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.75 |
| ▸ | SCN1A | P35498 | 4/20 | 0.61 |
| ▸ | SCN2A | Q99250 | 4/20 | 0.61 |
| ▸ | SCN3A | Q9NY46 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL89434 | 1.00 | CYP2D6 (0.75) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL14478711 | 1.00 | CYP2D6 (0.75) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL89117 | 1.00 | CYP2D6 (0.75) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL1322372 | 0.91 | CYP2D6 (0.80) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL10066282 | 0.91 | CYP2D6 (0.80) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL17543192 | 0.91 | CYP2D6 (0.80) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL522675 | 0.91 | CYP2D6 (0.80) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL17543030 | 0.91 | CYP2D6 (0.80) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL10066281 | 0.91 | CYP2D6 (0.80) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL14479807 | 0.90 | CYP2D6 (0.80) | CYP2D6KDM4EALDH1A1HSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2714687-B1 | PROCESS FOR THE PREPARATION OF PALIPERIDONE | CIPLA LTD (IN) | 2017-02-15 | — | — | EP | claimed |
| CN-113099718-B | Imidazole/thiol polymerization initiation system | 登士柏希罗纳有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-113099718-A | Initiation system for imidazole/thiol polymerization | 登士柏希罗纳有限公司 | 2021-07-09 | — | — | CN | disclosed |
| US-20120196927-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR METABOLIC SYNDROME | ERINA CO., INC. (JP) | 2012-08-02 | — | — | US | disclosed |
| EP-2434010-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR METABOLIC SYNDROME | Erina Co. Inc. (JP) | 2012-03-28 | — | — | EP | disclosed |
| EP-1468072-A1 | FERMENTED HERBAL HEALTH DRINK FROM PLANT ANDROGRAPHIS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH; An Indian Registered Body Incorporated Under The Registration of Societies Act; (IN) | 2004-10-20 | — | — | EP | disclosed |
| US-6616950-B2 | Also containing extract from barley, wheat, and/or fruit and ethanol, and optionally an extract from Tinospora; useful as an antioxidant, cardiotonic, diuretic, digestive, choleretic, nervine relaxant and immunomodulant | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-09-09 | — | — | US | disclosed |
| WO-2003062367-A1 | FERMENTED HERBAL HEALTH DRINK FROM PLANT $i(ANDROGRAPHIS) | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-07-31 | — | — | WO | disclosed |
| US-20030138509-A1 | FERMENTED HERBAL HEALTH DRINK FROM PLANT ANDROGRAPHIS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-07-24 | — | — | US | disclosed |
| US-5461080-A | Using vapor phase antioxidant | VYREX CORPORATION (US) | 1995-10-24 | — | — | US | disclosed |
| US-4387311-A | CALCIUM CARBONATE, GLASS FIBERS, ALUMINUM HYDROXIDE | HITACHI, LTD. (JP) | 1983-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120196927-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR METABOLIC SYNDROME | FABP4, GYS1, CPT1B | CYP2D6 3053/4885KDM4E 3563/4885ALDH1A1 1977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.